Skip to main content
SpringerLink
Log in

The 5-hydroxytryptamine receptor of blood platelets

  • Published:
Journal of Neural Transmission Aims and scope Submit manuscript

Summary

Blood platelets show specific, high affinity binding of3H-5-hydroxytryptamine,3H-ketanserin and3H-D-lysergic acid diethylamide. 5-HT-antagonists are considerably more potent than agonists regarding both the displacement of specifically bound3H-ketanserin and the shape change reaction mediated by the 5-HT-receptor. The latter depends on a rise of free intracellular Ca2. The binding site for3H-ketanserin and the site at which the 5-HT-induced shape change is triggered show the characteristics of a 5-HT2-receptor whose intracellular mediator seems to be Ca2+. The 5-HT2-receptor of platelets may be used as a partial model for that in neurons; however, it remains to be elucidated whether Ca2+ is a mediator of the latter.

Studies of receptors in blood platelets are of interest for several reasons. In platelets, the investigation of a whole chain of events is possible, starting with receptor-ligand interaction and leading via intracellular messengers to the expression of a morphological alteration,e.g. in case of the 5-hydroxytryptamine (5-HT) receptor the shape change reaction. Furthermore, the 5-HT-receptors of platelets have certain similarities with those of the central nervous system (CNS), which is one of the reasons why platelets can be used as a limited model for neurons. Finally, platelets are easily accessible, intact cells enabling receptor studies in man as a complement to animal experiments.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Affolter, H., Erne, P., Bürgisser, E., Pletscher, A.: Ca2+ as a messenger of 5HT2-receptor stimulation in human blood platelets. (Submitted for publication.)

  • Bennett, J. P., Snyder, S. H.: Serotonin and lysergic acid diethylamide binding in rat brain membranes: relationship to postsynaptic serotonin receptors. Mol. Pharmacol.12, 373–389 (1976).

    Google Scholar 

  • Drummond, A. H.: Interactions of blood platelets with biogenic amines: uptake, stimulation and receptor binding. In: Platelets in Biology and Pathology (Gordon, J. L., ed.), pp. 203–239. Amsterdam-New York-Oxford: Elsevier/North-Holland Biomedical Press, North-Holland Publishing Company (1976).

    Google Scholar 

  • Erne, P., Bürgisser, E., Bühler, F.: Free calcium concentration in platelets closely related to blood pressure in normal and essential hypertensive subjects. (Submitted for publication.)

  • Graf, M., Pletscher, A.: Shape change of blood platelets-a model for cerebral 5-hydroxytryptamine receptors? Br. J. Pharmacol.65, 601–608 (1979).

    Google Scholar 

  • Laubscher, A., Pletscher, A.: Shape change and uptake of 5-hydroxytryptamine in human blood platelets: Action of neuropsychotropic drugs. Life Sci.24, 1833–1840 (1979).

    Google Scholar 

  • Laubscher, A., Pletscher, A.: Increase of cyclic GMP in blood platelets by biogenic amines-a receptor-mediated effect? J. Pharm. Pharmacol.32, 601 (1980).

    Google Scholar 

  • Leysen, J. E., Niemegeers, C. J. E., Tollenaere, J. P., Laduron, P. M.: Serotoninergic component of neuroleptic drugs. Nature272, 168–171 (1978).

    Google Scholar 

  • Leysen, J. E., Gommeren, W., De Clerk, F.: Demonstration of S2-receptor binding sites on cat blood platelets using3H-ketanserin. Eur. J. Pharmacol.88, 125–130 (1983).

    Google Scholar 

  • Ögren, S. O., Fuxe, K., Agnati, L. F., Gustafsson, J. A., Jonsson, G., Holm, A. C.: Re-evaluation of the indolamine hypothesis of depression. Evidence for a reduction of functional activity of central 5 HT-systems by antidepressant drugs. J. Neural Transm.46, 85–103 (1979).

    Google Scholar 

  • Pellmar, T. C.: Transmitter-induced calcium current. Fed. Proc.40, 2631–2636 (1981).

    Google Scholar 

  • Peroutka, S. J., Snyder, S. S.: Multiple serotonin receptors: differential binding of3H-5-hydroxytryptamine,3H-lysergic acid diethylamide and3H-spiroperidol. Mol. Pharmacol.16, 687–699 (1979).

    Google Scholar 

  • Peroutka, S. J., Lebovitz, R. M., Snyder, S. S.: Two distinct central serotonin receptors with different physiological functions. Science212, 827–829 (1981).

    Google Scholar 

  • Tsien, R. Y., Pozzan, T., Rink, T. J.: Calcium homeostasis in intact lymphocytes: cytoplasmic free calcium monitored with a new, intracellularly trapped fluorescent indicator. J. Cell Biol.94, 325–334 (1982).

    Google Scholar 

  • Vanhoutte, P. M.: 5-Hydroxytryptamine and vascular disease. Fed. Proc.42, 233–237 (1983).

    Google Scholar 

  • Von Hahn, H. P., Honegger, C. G., Pletscher, A.: Similar kinetic characteristics of 5-hydroxytryptamine binding in blood platelets and brain membranes of rats. Neurosci. Lett.20, 319–322 (1980).

    Google Scholar 

Download references

Author information

Author notes

  1. A. Pletscher

    Present address: Department of Research, Cantonal Hospital, Switzerland

Authors and Affiliations

  1. Department of Research, Cantonal Hospital, Switzerland

    H. Affolter

Authors
  1. A. Pletscher
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. Affolter
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

This work was supported by the Emil Barell Foundation and the A. and N. Bonizzi-Theler Foundation, Switzerland.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pletscher, A., Affolter, H. The 5-hydroxytryptamine receptor of blood platelets. J. Neural Transmission 57, 233–242 (1983). https://doi.org/10.1007/BF01248995

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01248995

Keywords

Search

Navigation